Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Hay

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Molecular Biology and Evolution|November 27, 2010
Charting the host adaptation of influenza virusesMario dos Reis, Asif U Tamuri, Alan J Hay, et al.
Antiviral Research|November 26, 2008
Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidolIrina A Leneva, Rupert J Russell, Yury S Boriskin, et al.
Zhonghua Yi Xue Za Zhi|October 29, 2010
[Impact of avian influenza virus H5N1 neuraminidase mutations on the activity of neuraminidase and the sensibility to neuraminidase inhibitors]Zi Chen, Yu-huang Zheng, Yipu Lin, et al.
Chemmedchem|January 22, 2009
Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivirBenoit Carbain, Patrick J Collins, Lori Callum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Influenza virus infection in travelers to tropical and subtropical countriesMargot Mutsch, Michela Tavernini, Arthur Marx, et al.
Immunology|March 29, 2002
Conditional ablation of T-cell development by a novel viral ion channel transgeneClaire A Smith, Christine M Graham, Kathleen Mathers, et al.
Antiviral Research|August 7, 2021
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral groupMichael G Ison, Frederick G Hayden, Alan J Hay, et al.
Plos Computational Biology|March 27, 2023
A Bayesian approach to incorporate structural data into the mapping of genotype to antigenic phenotype of influenza A(H3N2) virusesWilliam T Harvey, Vinny Davies, Rodney S Daniels, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2008
Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analoguesAntonios Kolocouris, Philip Spearpoint, Stephen R Martin, et al.
Antiviral Research|December 21, 2021
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conferenceJennifer L McKimm-Breschkin, Alan J Hay, Bin Cao, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Molecular Biology and Evolution|November 27, 2010
Charting the host adaptation of influenza virusesMario dos Reis, Asif U Tamuri, Alan J Hay, et al.
Antiviral Research|November 26, 2008
Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidolIrina A Leneva, Rupert J Russell, Yury S Boriskin, et al.
Zhonghua Yi Xue Za Zhi|October 29, 2010
[Impact of avian influenza virus H5N1 neuraminidase mutations on the activity of neuraminidase and the sensibility to neuraminidase inhibitors]Zi Chen, Yu-huang Zheng, Yipu Lin, et al.
Chemmedchem|January 22, 2009
Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivirBenoit Carbain, Patrick J Collins, Lori Callum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Influenza virus infection in travelers to tropical and subtropical countriesMargot Mutsch, Michela Tavernini, Arthur Marx, et al.
Immunology|March 29, 2002
Conditional ablation of T-cell development by a novel viral ion channel transgeneClaire A Smith, Christine M Graham, Kathleen Mathers, et al.
Antiviral Research|August 7, 2021
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral groupMichael G Ison, Frederick G Hayden, Alan J Hay, et al.
Plos Computational Biology|March 27, 2023
A Bayesian approach to incorporate structural data into the mapping of genotype to antigenic phenotype of influenza A(H3N2) virusesWilliam T Harvey, Vinny Davies, Rodney S Daniels, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2008
Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analoguesAntonios Kolocouris, Philip Spearpoint, Stephen R Martin, et al.
Antiviral Research|December 21, 2021
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conferenceJennifer L McKimm-Breschkin, Alan J Hay, Bin Cao, et al.
Pageof 3